Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flumazenil and Gabapentin for Alcohol Withdrawal and Relapse Prevention
NCT00262639Phase 3Completed
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2005
- Primary completion
- Feb 2008
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of flumazenil and gabapentin in alcohol dependence, sponsored by Medical University of South Carolina. Primary endpoint: Percent Subjects Completely Abstinent at 6 weeks. Started Dec 2005; status: completed.
02
Drugs
flumazenilgabapentin
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00262639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262639.